RecruitingNot ApplicableNCT04744935
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Sponsor
Christopher Zachary
Enrollment
40 participants
Start Date
Jan 13, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Optical coherence tomography guided laser treatment of basal cell carcinoma
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Ability to understand and carry out subject instructions or be represented by a legally authorized guardian or representative
- Ages 18 and older
- Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy
Exclusion Criteria7
- Any of the following will exclude participation in the study:
- Inability to understand and/or carry out instructions
- Patients with a BCC lesion that requires excision. This would include relatively large lesions (\>2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth of the OCT image capture, high risk lesions as defined by the American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases.
- Patients with periocular BCCs which might expose the patient to risk of damage to eyes from the laser.
- BCCs on legs due to their tendency towards poor wound healing.
- Pregnancy
- Patients unable to follow-up for the full 12 months.
Interventions
DEVICE1064 nm long-pulse Nd:YAG laser
BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04744935
Related Trials
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
NCT0434943628 locations
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
NCT071822401 location
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
NCT066244753 locations
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
NCT072850441 location
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
NCT058590747 locations